Private Equity Firm Healthcare

Noro-Moseley Partners

Atlanta, GA, United States

Providing leading entrepreneurs with energy, connections and expertise to build world-class companies. Vertically-focused within information technology and healthcare, with investment expertise and a track record in both sectors.

Focus Areas
Healthcare IT, Healthcare services, Information technology
Website
noromoseley.com

Tracked deals

4

4 tracked deals across 2019-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Growth capital

2 growth capital · 1 buyout · 1 recapitalization

Noro-Moseley Partners Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Noro-Moseley Partners. 1 2019 2 2021 1 2023

Supporting Data

Recent Transactions

  • Buyer
    Medix Infusion, Echo Health Ventures, Pittco Direct Investments II, Noro-Moseley Partners
    Target
    Infusion operations of the Center for Neurology and Spine
    Seller
    Center for Neurology and Spine

    Medix Infusion closed a $35 million Series B led by Echo Health Ventures with participation from Pittco Direct Investments II and Noro-Moseley Partners, and simultaneously secured a debt facility with Live Oak Bank. Medix will use the capital to support organic growth and to acquire the infusion operations of the Center for Neurology and Spine, expanding its ambulatory infusion footprint into Arizona.

  • Buyer
    Elligo Health Research, Morgan Stanley Expansion Capital, Ally Bridge Group, Norwest Venture Partners, Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, Syneos Health
    Target
    ClinEdge, GuideStar Research, BTC of New Bedford
    Type
    Buyout

    Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.

  • Buyer
    Heritage Group, Noro-Moseley Partners, Blue Venture Fund, Windham Ventures
    Target
    Upward Health

    Upward Health, a Providence-based in-home medical group focused on high-risk, high-need populations, raised a growth equity financing led by Heritage Group with participation from existing investors Noro-Moseley Partners, the Blue Venture Fund and Windham Ventures. The capital will support Upward Health’s continued growth and national expansion of its risk-bearing, in-home care model integrating physical, behavioral and social services.

  • Buyer
    Primus Capital, Providence Ventures, Martin Ventures, Noro-Moseley Partners, Nashville Capital Network
    Target
    Trilliant Health
    Industry
    Data & Analytics

    Primus Capital led a major growth investment and recapitalization in Trilliant Health, a healthcare analytics company based near Nashville, Tennessee. Existing investors — Providence Ventures, Martin Ventures, Noro-Moseley Partners, and Nashville Capital Network — also participated to support Trilliant’s product development, data science hiring, and national expansion of its analytics platform for health systems.

Related Acquisition Pages

Selling a company? Get in front of buyers like Noro-Moseley Partners

Turn tracked acquisition activity into an outreach-ready buyer list.